CompletedPhase 4NCT03363295
Evaluation of Macular Changes After Intracameral Moxifloxacin for Prevention of Endophthalmitis
Studying Endophthalmitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Universidade Federal de Pernambuco
- Principal Investigator
- Mathias V Mélega, MDUniversity of Campinas, Brazil
- Intervention
- Moxifloxacin Injection(drug)
- Enrollment
- 120 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2017 – 2019
Study locations (1)
- Hospital das Clínicas da UNICAMP, Campinas, São Paulo, Brazil
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03363295 on ClinicalTrials.govOther trials for Endophthalmitis
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNCT07176130Demographics and Clinical Characteristics of Ocular Inflammatory Diseases in SingaporeSingapore National Eye Centre
- RECRUITINGNCT07175311Vascular Changes Associated With Endophthalmitis.Asociación para Evitar la Ceguera en México
- RECRUITINGNCT05432336Complex Ocular Infection, Optimization of Microbiological DiagnosisAssistance Publique - Hôpitaux de Paris
- RECRUITINGNCT05372861Nanopore Sequencing in OphthalmologyMedical University of Graz